Hesham Elarabi

Cross disciplinary health care professional in mental health and addiction with clinical, research, strategy 'think-thank', service development, program management,capacity building, community medicine and public health experience

Establish professional development certifications (Psychological Skills Diploma), develop measurement based inpatient and residential care for co-ocurring substance use and mental health disorder, establish opioid assisted treatment program, establish surveillance frame work, develop clinical and prevention guidelines for substance use related disorders published by the United Nations Office on Drug and Crime, Patent for Point of Care Test to expand and optimize opioid assisted treatment (expected award June 2024)

• Board Certified Psychiatric Pharmacists (BCPP), Board of Pharmaceutical Specialties, USA- American Association of Psychiatric Pharmacists, 2010
• International Certification of Addiction Practitioner II, Global Centre for Credentialing and Certification (GCCC)
• Certificate in Global Mental Health, Harvard Program in Refugee Trauma, USA, 2013
• International Diploma in Project Management (HIDPM), Cambridge University, UK, 2009
• Precision Medicine: Applied Pharmacogenomics Certificate, American College of Clinical Pharmacy
• Medication Therapy Management Certificate, American College of Clinical Pharmacy
• Essentials of Dialectic Behavioral Therapy, Association of Psychological Therapy, UK, 2023
• Cognitive Behavioral Therapy Workshops, Oxford University Center of Cognitive Behavioral Therapy, 2017-2018
• Certificate in Health Economics and Policy, London School of Economics and Health Policy, 2024
• Board Certified in Medical Affairs Specialist, Board Certification in Medical Affairs, 2024

• Data management, modelling and visualization using Tableua.
• Proficient in Statistical Package for Social Sciences (SPSS), R / Jamovi, STATA, Minitab.

• Reviewer for International Journals: Drug and Alcohol Dependence; American Journal of Drug and Alcohol Abuse; Drug and Alcohol Review; Scientific Reports; Frontiers in Psychiatry, Systematic Reviews, Drugs; Education, Prevention and Policy, Substance Abuse Treatment, Prevention and Policy.
• Member of the Treatment Advisory Group for the United Nations Office on Drug and Crime and World Health Organization Global Program (March 2012)
• Assistant Editor- International Journal on Prevention and Substance Use Disorders, 2012- to 2016
• Representative on collaborative projects with United Nations Office on Drug and Crime, 2010-2012
• Member of the expert group on International Standards for Drug Use Prevention by the United Nations Office on Drugs and Crime, 2013.
• National Rehabilitation Center, Deputy Committee Chair: Human Resource and Recruitment, Legislative and Policy Committee, Education and Therapeutic Capacity building committee – National Rehabilitation Center, 2009-201, Task force leader of therapeutic program planning project, 2010

• Date of Birth: 04/03/77
• Nationality: Canadian

• Lower buprenorphine elimination rate constant is associated with lower opioid use, Elarabi, H. F., Lee, A. J., Adem, A., Elrasheed, A., Marsden, J., & Al Ghaferi, H., Psychopharmacology, 239, 10, 3213–3221, 2022, https://doi.org/10.1007/s00213-022-06202-9
• Polysubstance Use in Adults With Opioid Use Disorder Receiving Buprenorphine Maintenance, Elarabi, H. F., Radwan, D. N., Adem, A., Marsden, J., & Lee, A. J., Journal of addiction medicine, https://doi.org/10.1097/ADM.0000000000001039
• Exploratory Economic Evaluation of Buprenorphine Treatment in Opioid Use Disorder, Elarabi, H.F., Al Ghaferi .H., Gawad, T.A., Hasan, N., Shawky, M., Al Kathiri, H., Al Maamari, S., Radwan, D., Lee, A.J., Adem, A., Marsden, J., The Journal of Mental Health Policy and Economics, 24, 89-95
• Effectiveness of incentivised adherence and abstinence monitoring in buprenorphine maintenance: a pragmatic, randomised controlled trial, Elarabi, H. F., Shawky, M., Mustafa, N., Radwan, D., Elarasheed, A., Yousif Ali, A., Osman, M., Kashmar, A., Al Kathiri, H., Gawad, T., Kodera, A., Al Jneibi, M., Adem, A., Lee, A. J., & Marsden, J., Addiction, 10.1111/add.15394
• The impact of family engagement in opioid assisted treatment: Results from a randomised controlled trial, AlGhaferi, H., Hasan, N., Elarabi, H.F., Radwan, D., Shawky, M., Al Mamari, S., Abdelgawad, T., Elrasheed, A., Kodera, A., Al Kathiri, H., Wanigaratne, S., International Journal of Social Psychiatry, 10.1177/0020764020979026
• Therapeutic Drug Monitoring in Buprenorphine/Naloxone Treatment for Opioid Use Disorder: Clinical Feasibility and Optimizing Assay Precision, Elarabi, H., Hasan, N., Marsden, J., Radwan, D., Adem, A., Almamari, S., Elrasheed, A., Pharmacopsychiatry, 10.1055/a-1083-6842
• Suboxone Treatment and Recovery Trial (STAR-T). Study protocol for a randomised controlled trial of opioid medication of Opioid Medication Assisted Treatment with Adjunct Medication Management Using Therapeutic Drug Monitoring and Contingency Management, Elarabi, H., Elrasheed, A., Ali, A., Shawky, M., Hasan, N., Gawad, T.A., Adem, A. and Marsden, J., Journal of Addiction, 10.1155/2019/2491063
• Assessment of the Use of Point-Of –Care Pregabalin Testing For Drug Monitoring, Compared to Gas Chromatography Mass-Spectrometry – A Pilot Study, Al Ghafri, H., Elrasheed, A., Al Mamari, S., Assaf, M., Al Jenaibi, M. Elarabi, H., Alawadhi, A., Rashid, A., Al Meheri, A., Jawad, T., Yousif, A. and Elliott, S., Journal of Medical Toxicology and Clinical Forensic Medicine, 4, 1, 1-3, 10.21767/2471-9641.100032
• Parents’ Perceptions and Beliefs on Adolescence and Substance Use: A Preliminary Qualitative Study in Abu Dhabi, United Arab Emirates (UAE), Alhyas, L., Elarabi, H., El-Kashef, A., Wanigaratne, S., Almarzouqi, A., Alhosani, A and Al Ghaferi, H., Journal of Child and Adolescent Behavior, 3, 2, 1-6, 10.4172/2375-4494.1000195
• Adolescents’ perceptions of substance use and factors influencing its use: a qualitative study in Abu Dhabi, United Arab Emirates (UAE), Alhyas, L., Al Ozaibi, N., Elarabi, H., El-Kashef, A., Wanigaratne, S., Al Marzouqi, Al Hosani, A. and Al Ghaferi, H., Journal of the Royal Society of Medicine, 6, 2, 1-12, 10.1177/2054270414567167
• Transforming a residential substance dependence program: Experience from the National Rehabilitation Centre, United Arab Emirates, Elarabi, H., Al Hamedi, F., Wanigaratne, S., Mental Health and Substance Use: Dual Diagnosis, 7, 4, 353-362
• Rapid Analysis of Knowledge Attitudes and Practices towards substance addiction across different target groups in Abu Dhabi City, United Arab Emirates, Elarabi, H., Hajal, S., Salas, S., Wanigaratne, S., Drug and Alcohol Review, 32, supplement 1, 2 – 74

• Dr. Shamil Wanigratne, Clinical Psychologist, Institute of Psychiatry, Pyschology and Neuroscience, King’s College London, Shamil.wanigaratne@kcl.ac.uk
• Professor John Marsden, Division of Academic Psychiatry- Addictions Department, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, John.marsden@kcl.ac.uk